Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BiognostiX Symposium Draws a Crowd to Hauser Forum

Published: Thursday, May 15, 2014
Last Updated: Wednesday, May 14, 2014
Bookmark and Share
Company to share the results of this 3-year EU funded FP7 research programme.

FFEI Life Science has successfully concluded phase I of the BiognostiX project with a symposium to share the results of this 3-year EU funded FP7 research programme. Delegates to the event, held at the Hauser Forum, Cambridge, UK on Thursday 27 February.

Led by FFEI, the BiognostiX Consortium has developed a radical new approach to performing diagnostic tests at point-of-use, with potential applications in veterinary, agri-food and human diagnostics. The BiognostiX technology uses a multiplex microfluidic platform and newly invented Immuno-Ink to deliver fast, flexible, single-use tests in a format that anyone can use.

The test is performed on a BiognostiX Chip, which combines the desired biochemistry and microfluidics with a novel technology platform. A microfluidic channel is engineered on the paper-based surface of the chip and reagents are printed to specific zones of the channel using fluid-jet printing technologies, thus enabling simultaneous performance of multiple tests per sample.

The simplicity of this approach facilitates changes in assay configuration during the development process, which when optimized, can then be fixed for simple, low-cost manufacture.

George Hutchinson, Director, FFEI Life Science commented, “This has been an fascinating project to be involved with, particularly as the consortium has brought together teams from across Europe with different areas of expertise. We are delighted that we have now been able to demonstrate proof-of-principle and look forward to further collaboration to take this project forward.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!